David M. Gershenson

814 total citations
16 papers, 530 citations indexed

About

David M. Gershenson is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, David M. Gershenson has authored 16 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in David M. Gershenson's work include Ovarian cancer diagnosis and treatment (10 papers), Reproductive Biology and Fertility (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). David M. Gershenson is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Reproductive Biology and Fertility (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). David M. Gershenson collaborates with scholars based in United States. David M. Gershenson's co-authors include Diane C. Bodurka, Judith K. Wolf, J.Taylor Wharton, Charles Lev́enback, J. Taylor Wharton, Christopher R. Matthews, Michael J. Morris, Jubilee B. Robinson, Adnan Munkarah and Diljeet K. Singh and has published in prestigious journals such as Obstetrics and Gynecology, Gynecologic Oncology and International Journal of Gynecology & Obstetrics.

In The Last Decade

David M. Gershenson

16 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Gershenson United States	12	351	204	171	81	67	16	530
Linda S. Morgan United States	14	257 0.7×	149 0.7×	342 2.0×	20 0.2×	25 0.4×	28	607
James E. Delmore United States	13	245 0.7×	135 0.7×	176 1.0×	55 0.7×	7 0.1×	25	520
Charlotte Gerd Hannibal Denmark	18	551 1.6×	174 0.9×	266 1.6×	141 1.7×	19 0.3×	34	842
Danny Barnhill United States	14	162 0.5×	110 0.5×	152 0.9×	70 0.9×	7 0.1×	30	431
Aida Moeini United States	14	149 0.4×	42 0.2×	282 1.6×	35 0.4×	22 0.3×	31	519
S Arkwright France	8	411 1.2×	83 0.4×	314 1.8×	27 0.3×	27 0.4×	22	504
Rodrique Mortel United States	12	533 1.5×	427 2.1×	500 2.9×	81 1.0×	13 0.2×	17	1.0k
Sergei Zehavi Israel	11	189 0.5×	83 0.4×	140 0.8×	76 0.9×	3 0.0×	19	417
Tim Hillard United Kingdom	11	154 0.4×	71 0.3×	96 0.6×	54 0.7×	11 0.2×	31	760
Fuat Demirkıran Türkiye	16	436 1.2×	166 0.8×	451 2.6×	39 0.5×	4 0.1×	76	775

Countries citing papers authored by David M. Gershenson

Since Specialization

Citations

This map shows the geographic impact of David M. Gershenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Gershenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Gershenson more than expected).

Fields of papers citing papers by David M. Gershenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Gershenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Gershenson. The network helps show where David M. Gershenson may publish in the future.

Co-authorship network of co-authors of David M. Gershenson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Gershenson. A scholar is included among the top collaborators of David M. Gershenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Gershenson. David M. Gershenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Brown, Jubilee, Austin Miller, Laura L. Holman, et al.. (2024). Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14. Gynecologic Oncology. 190. 283–290. 6 indexed citations

Eddy, Gary L., et al.. (2009). Fallopian Tube Carcinoma. Gynecologic Oncology. 64(4). 167–174. 11 indexed citations

Milam, Michael R., Jian Gu, Haopeng Yang, et al.. (2007). STK15 F31I polymorphism is associated with increased uterine cancer risk: A pilot study☆. Gynecologic Oncology. 107(1). 71–74. 21 indexed citations

Robinson, Jubilee B., Diljeet K. Singh, Diane C. Bodurka, et al.. (2001). Hypersensitivity Reactions and the Utility of Oral and Intravenous Desensitization in Patients with Gynecologic Malignancies. Gynecologic Oncology. 82(3). 550–558. 96 indexed citations

Munkarah, Adnan, Charles Levenback, Judith K. Wolf, et al.. (2001). Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer. Gynecologic Oncology. 81(2). 237–241. 77 indexed citations

Gordinier, Mary E., Lois M. Ramondetta, Lynn P. Parker, et al.. (2000). Survey of Female Gynecologic Oncologists and Fellows: Balancing Professional and Personal Life. Gynecologic Oncology. 79(2). 309–314. 23 indexed citations

Gershenson, David M.. (1999). Contemporary Treatment of Borderline Ovarian Tumors. Cancer Investigation. 17(3). 206–210. 41 indexed citations

Morris, Michael H., et al.. (1997). An outcomes management program in gynecologic oncology. Obstetrics and Gynecology. 89(4). 485–492. 24 indexed citations

Gershenson, David M., et al.. (1996). Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstetrics and Gynecology. 87(4). 527–531. 100 indexed citations

10.

Gershenson, David M., Thomas W. Burke, C. Levenback, et al.. (1995). Combined Cisplatin and Carboplatin Chemotherapy for Treatment of Advanced Epithelial Ovarian Cancer. Gynecologic Oncology. 58(3). 349–355. 14 indexed citations

11.

Munkarah, Adnan, David M. Gershenson, Charles Levenback, et al.. (1994). Salvage Surgery for Chemorefractory Ovarian Germ Cell Tumors. Gynecologic Oncology. 55(2). 217–223. 35 indexed citations

12.

Burke, Thomas W., et al.. (1992). Minimally invasive vulvar carcinoma: An indication for conservative surgical therapy. Gynecologic Oncology. 44(3). 240–244. 24 indexed citations

13.

Gershenson, David M., et al.. (1991). Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecologic Oncology. 40(2). 169–169. 3 indexed citations

14.

Lev́enback, Charles, et al.. (1991). Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecologic Oncology. 40(2). 191–192. 2 indexed citations

15.

Delmore, James E., et al.. (1987). Preoperative radiotherapy for early endometrial carcinoma. Gynecologic Oncology. 28(1). 34–40. 1 indexed citations

16.

Kavanagh, J. J., et al.. (1986). Tamoxifen therapy of epithelial ovarian cancer. International Journal of Gynecology & Obstetrics. 24(5). 386–386. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact